Showing results (1041-1050 of 1,221) with videos related to
Sort By:
Pageof 123
Pediatric Blood & Cancer|June 15, 2011
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) studyHeidi V Russell, Susan G Groshen, Tasnim Ara, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.Proceedings. Biological Sciences|September 26, 2019
Plumage redness signals mitochondrial function in the house finchGeoffrey E Hill, Wendy R Hood, Zhiyuan Ge, et al.Journal of Adolescent and Young Adult Oncology|January 27, 2023
Adaptation and Development of a Health Insurance Education Program for Adolescent and Young Adult Cancer PatientsPerla L Vaca Lopez, Echo L Warner, Austin R Waters, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) ReportNavin Pinto, Arlene Naranjo, Xiangming Ding, et al.JAMA Network Open|February 14, 2025
Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group ReportPuja J Umaretiya, Arlene Naranjo, Fan F Zhang, et al.Journal of Pain and Symptom Management|May 4, 2020
Racial and Ethnic Differences in Communication and Care for Children With Advanced CancerJennifer W Mack, Hajime Uno, Clare J Twist, et al.Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.Pediatric Blood & Cancer|December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2017
Coping and Prognostic Awareness in Patients With Advanced CancerRyan D Nipp, Joseph A Greer, Areej El-Jawahri, et al.Pageof 123